Madam Speaker, my thoughts go out to all who suffer from MS. We are moving as quickly as possible based on the best available science. We have established a scientific expert working group to monitor and analyze results from the seven MS Society sponsored studies already under way in Canada and the United States.
This year the CIHR has invested $5.4 million specifically for MS.
If the experts advise in favour of clinical trials, our government working with the MS Society and provinces and territories will ensure they are funded, again based on the best available science.
I appreciate the opportunity to have spoken on this very important issue.